PageOverview.com
 

Domains targeting keyword avanir

Keyword avanir was used in the provided list of websites.

 
Number of websites/domains displayed: 12
Results found: 12
 

Websites discovered:

American Association of Directors of Nursing Services AADNS
http://pageoverview.com/website-report/aadns-ltc.org
  • Expected expiration: August 26th in 2019
  • Creation date: August 26th in 2015
  • Renew date: August 27th in 2017
  • Google Analytics: 74322027-1
Sign in to your account
http://pageoverview.com/website-report/avanir.sharepoint.com
    California Pharmacists Association > Home
    http://pageoverview.com/website-report/cpha.com
    • Expected expiration: July 26th in 2019
    • Creation date: July 27th in 1995
    • Renew date: May 9th in 2017
    • Google Analytics: 16120141-1
    PseudoBulbar Affect: Causes, PBA Quiz, and Management | PBAInfo
    http://pageoverview.com/website-report/pbainfo.org
    Learn more about PseudoBulbar Affect (PBA), a secondary neurologic condition that causes sudden, frequent, and uncontrollable crying and/or laughing that doesn't match feelings.
    • Expected expiration: December 18th in 2019
    • Creation date: December 18th in 2007
    • Renew date: March 29th in 2017
    The 21st IAGG World Congress of Gerontology and Geriatrics - San Francisco, July 23-27, 2017
    http://pageoverview.com/website-report/iagg2017.org
    • Expected expiration: April 30th in 2022
    • Creation date: April 30th in 2012
    • Renew date: November 12th in 2015
    • Google Analytics: 23087110-1
    Cutting Edge Information
    http://pageoverview.com/website-report/cuttingedgeinfo.com
    Cutting Edge Information provides decision support for pharma and medical device leaders with primary data, benchmarking reports & customized research
    • Expected expiration: November 7th in 2024
    • Creation date: November 7th in 2001
    • Renew date: March 11th in 2016
    • Google Analytics: 409467-11
    NUEDEXTA® (dextromethorphan HBr 20 mg and quinidine sulfate 10 mg) capsules
    http://pageoverview.com/website-report/nuedexta.com
    Learn about NUEDEXTA, the only treatment approved by the FDA to treat PBA. See full safety & prescribing info.
    • Expected expiration: March 31st in 2018
    • Creation date: March 31st in 2010
    • Renew date: August 15th in 2016
    Home | Avanir Pharmaceuticals
    http://pageoverview.com/website-report/avanir.com
    Avanir Pharmaceuticals is dedicated to the research and development of cutting-edge treatments and therapies for disorders of the central nervous system (CNS).
    • Expected expiration: December 16th in 2021
    • Creation date: December 16th in 1998
    • Renew date: June 23rd in 2013
    Home - PhRMA Foundation
    http://pageoverview.com/website-report/phrmafoundation.org
    • Expected expiration: April 27th in 2019
    • Creation date: April 27th in 2000
    • Renew date: January 20th in 2015
    • Google Analytics: 42525349-1
    PseudoBulbar Affect: Causes, PBA Quiz, and Management | PBAInfo
    http://pageoverview.com/website-report/pbafacts.com
    Learn more about PseudoBulbar Affect (PBA), a secondary neurologic condition that causes sudden, frequent, and uncontrollable crying and/or laughing that doesn't match feelings.
    • Expected expiration: July 27th in 2018
    • Creation date: July 27th in 2012
    • Renew date: May 28th in 2015
    Motionstrand Digital Agency | Web Design, Development, Marketing
    http://pageoverview.com/website-report/motionstrand.com
    We are a full-service digital agency located in Southern California. We craft eloquent user experiences that connect brands to their audience.
    • Expected expiration: August 9th in 2019
    • Creation date: August 9th in 2005
    • Renew date: March 12th in 2016
    AANAC
    http://pageoverview.com/website-report/aanac.org
    • Expected expiration: November 27th in 2017
    • Creation date: November 28th in 1998
    • Renew date: December 7th in 2015
    • Google Analytics: 20245133-3
    0.0103 // 2024-05-26 15:44:02
    All Rights reserved 2018 © PageOverview.com